Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-24-236708
Filing Date
2024-10-11
Accepted
2024-10-11 16:01:41
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d882769d424b5.htm 424B5 10157
2 GRAPHIC g882769g1011183518893.jpg GRAPHIC 6049
  Complete submission text file 0001193125-24-236708.txt   19820
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-267795 | Film No.: 241367538
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)